Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03407066 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Perception, Sensation, Cognition and Action in Humans

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 8 years later Dec 31, 2027 → Dec 31, 2035
See other at-risk trials from National Eye Institute (NEI)

Record History

The 50 most recent of 421 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Minor Eligibility criteria expanded, about 25 words
    • Study description expanded, about 6 words
  2. Minor 5 versions Re-verified since Aug 19, 2026, no change to tracked fieldsv416-v420
  3. Notable Primary and study completion pushed from Dec 31, 2027 to Dec 31, 2035
    • Trial arms changed: 2 → 3
    v415
  4. Minor 13 versions Re-verified since Mar 18, 2026, no change to tracked fieldsv402-v414
  5. Minor Study description expanded, about 43 wordsv401
Show 29 earlier versionsHide 29 earlier versions
  1. Minor 2 versions Re-verified since Oct 16, 2025, no change to tracked fieldsv399-v400
  2. Minor Eligibility criteria expanded, about 2 wordsv398
  3. Minor 4 versions Re-verified since Jul 31, 2025, no change to tracked fieldsv394-v397
  4. Minor Eligibility criteria shortened, about 3 words
    • Study description shortened, about 5 words
    v393
  5. Minor Re-verified, no change to tracked fieldsv392
  6. Minor Enrollment target: 10100 to 10200
    • Eligibility criteria revised
    v391
  7. Minor Enrollment target: 10200 to 10100
    • Eligibility criteria expanded, about 178 words
    • Study description expanded, about 8 words
    v390
  8. Minor Re-verified, no change to tracked fieldsv389
  9. Notable Primary and study completion dates: Dec 31, 2025 to Dec 31, 2027v388
  10. Minor 2 versions Re-verified since Oct 17, 2023, no change to tracked fieldsv386-v387
  11. Minor Study Status, Study Description, Eligibilityv385
  12. Minor 2 versions Re-verified since Nov 30, 2022, no change to tracked fieldsv383-v384
  13. Minor Study Status, Outcome Measuresv382
  14. Minor 10 versions Re-verified since Jun 23, 2022, no change to tracked fieldsv372-v381
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: When people see and hear, the brain changes signals from the eyes and ears into perceptions and thoughts. No one fully understands how this happens. Researchers want to explore how healthy brains process sights and sounds. Objectives: To explore how people understand what they see and hear when the brain processes sights and sounds. Eligibility: Participants aged 13-65 who have at least 20/40 vision in at least one eye and do not use a hearing aid. Design: Some participants will take tests online anonymously. They will do computer tasks related to colors and behavior. In-person participants will be screened with medical history and physical exam. They will complete questionnaires and vision and hearing tests. Off-site participants will be screened with questionnaires about themselves and their vision. If results indicate abnormal color vision, these off-site participants may be asked to provide saliva samples for genetic screening. In-person participants will plan how many testing sessions they will have and when. Sessions last 2-5 hours. They may include: * Magnetic Resonance Imaging: Magnets and radio waves to take pictures of the brain. Participants will lie on a table that slides in and out of a tube. They will do a task during the scan. * Magnetoencephalography: Records magnetic field changes from brain activity. Participants will sit or lie down. A cone will be lowered onto their head. They may do a task during the test. * Electromyography: Electrodes attached to the skin will measure the electrical activity of muscles. * Electroencephalogram: Electrodes on the scalp will record brain waves. * Electrocardiography: Electrodes on the chest will record heart electrical activity. * Tests of memory, attention, thinking, vision, and hearing. * Eye Tracking: Cameras will follow participants eye movements. They may wear a cap with infrared cameras in front of their eyes. During the sessions, participants vital signs may be monitored.
Trial Details
NCT Number NCT03407066
Lead Sponsor National Eye Institute (NEI)
Conditions
(from sponsor)
Normal Physiology
Enrollment 10,200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov